Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 107, Issue , 2013, Pages 235-244

  Madan, Jitender ^a,b   Pandey, Ravi S ^c   Jain, Upendra Kumar ^b   Katare, Om P ^d   Aneja, Ritu ^a   Katyal, Anju ^e  

^a GEORGIA STATE UNIVERSITY   (United States)

^b Chandigarh College of Pharmacy   (India)

^c GURU GHASIDAS UNIVERSITY   (India)

^d PANJAB UNIVERSITY   (India)

^e UNIVERSITY OF DELHI   (India)

Author keywords

Cytotoxicity; Gelatin microassemblies; Lung; Noscapine; Pharmacokinetics

Indexed keywords

ENTRAPMENT EFFICIENCY; LUNG; MICROASSEMBLIES; NON SMALL CELL LUNG CANCER; NOSCAPINE; POLYMER INTERACTIONS; THERAPEUTIC EFFECTS; THERAPEUTIC EFFICACY;

BIOCHEMISTRY; CELL DEATH; CYTOTOXICITY; DISEASES; DRUG DELIVERY; PHARMACOKINETICS;

BIOLOGICAL ORGANS;

CASPASE 3; GELATIN; MACROGOL; MICROSPHERE; NOSCAPINE; POLYMER; STERICALLY STABILIZED GELATIN MICROASSEMBLIES; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER CELL; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; GELATIN; GLUTARAL; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LUNG NEOPLASMS; MALE; MICE; MICROSPHERES; NOSCAPINE; PARTICLE SIZE; STATIC ELECTRICITY; SURFACE PROPERTIES; TEMPERATURE; TISSUE DISTRIBUTION;

EID: 84875076771     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.02.010     Document Type: Article

References (41)

1. Saintigny P., Burger J.A. Discov. Med. 2012, 13:287.
2. Stanton R.A., Gernert K.M., Nettles J.H., Aneja R. Med. Res. Rev. 2011, 31:443.
3. Aneja R., Zhou J., Zhou B., Chandra R., Joshi H.C. Mol. Cancer Ther. 2006, 5:2366.
4. Aneja R., Vangapandu S.N., Lopus M., Chandra R., Panda D., Joshi H.C. Mol. Pharmacol. 2006, 69:1801.
5. Barken I., Geller J., Rogosnitzky M. Anticancer Res. 2010, 30:399.
6. Jackson T., Chougule M.B., Ichite N., Patlolla R.R., Singh M. Cancer Chemother. Pharmacol. 2008, 63:117.
7. Chougule M.B., Patel A., Sachdeva P., Jackson T., Singh M. PLoS One 2011, 6:e27394.
8. Gibaldi M., Weiner N.D. J. Pharm. Sci. 1966, 55:769.
9. Aneja R., Dhiman N., Idnani J., Awasthi A., Arora S.K., Chandra R., Joshi H.C. Cancer Chemother. Pharmacol. 2007, 60:831.
10. Ryu J.H., Koo H., Sun I.C., Yuk S.H., Choi K., Kim K., Kwon I.C. Adv. Drug Deliv. Rev. 2012, 64:1447.
11. Kurmi B.D., Kayat J., Gajbhiye V., Tekade R.K., Jain N.K. Expert Opin. Drug Deliv. 2010, 7:781.
12. Lu W., Xiong C., Zhang R., Shi L., Huang M., Zhang G., Song S., Huang Q., Liu G.Y., Li C. J. Control. Release 2012, 161:959.
13. Paciotti G.F., Kingston D.G.I., Tamarkin L. Drug Dev. Res. 2006, 67:47-54.
14. Huo D., Deng S., Li L., Ji J. Int. J. Pharm. 2005, 289:63.
15. Brown K.T., Vasc J. Interv. Radiol. 2004, 15:197.
16. Tabata Y., Ikada Y. Biomaterials 1988, 9:356.
17. Harper G.R., Davis S.S., Davies M.C., Norman M.E., Tadros T.F., Taylor D.C., Irving M.P., Waters J.A., Watts J.F. Biomaterials 1995, 16:427.
18. Wattendorf U., Merkle H.P. J. Pharm. Sci. 2008, 97:4655.
19. Madan J., Dhiman N., Parmar V.K., Sardana S., Bharatam P.V., Aneja R., Chandra R., Katyal A. Cancer Chemother. Pharmacol. 2010, 65:537.
20. Madan J., Dhiman N., Sardana S., Aneja R., Chandra R., Katyal A. Anticancer Drugs 2011, 22:543.
21. Alvi I.A., Madan J., Kaushik D., Sardana S., Pandey R.S., Ali A. Anticancer Drugs 2011, 22:774.
22. Madan J., Baruah B., Nagaraju M., Abdalla M.O., Yates C., Turner T., Rangari V., Hamelberg D., Aneja R. Mol. Pharmacol. 2012, 9:1470.
23. Abdalla M.O., Karna P., Sajja H.K., Mao H., Yates C., Turner T., Aneja R. J. Control. Release 2011, 149:314.
24. Kaul G., Amiji M. J. Drug Target. 2004, 12:585.
25. Yeh T.K., Lu Z., Wientjes M.G., Au J.L.S. Pharm. Res. 2005, 22:867.
26. Cardella J.A., Keshavjee S., Mourgeon E., Cassivi S.D., Fischer S., Isowa N., Slutsky A., Liu M. J. Appl. Phycol. 2000, 89:1553.
27. Muvaffak A., Gurhan I., Hasirci N. J. Microencapsul. 2004, 21:293.
28. Illum L., Davis S.S. J. Parent. Sci. Technol. 1982, 36:242.
29. Gupta P.K., Hung C.T., Perrier D.G. J. Pharm. Sci. 1987, 76:141.
30. Klimpel D., Cohon M.S. N. Engl. J. Med. 1969, 280:900.
31. Seidlitz A., Weitschies W. J. Pharm. Pharmacol. 2012, 64:969.
32. Tim M. J. Immunol. Methods 1983, 65:55.
33. Sharma A.K., Rohrer B. J. Biol. Chem. 2004, 279:35564.
34. Winter C.A., Flataker L. Toxicol. Appl. Pharmacol. 1961, 3:96.
35. Katti D., Krishnamurti N. J. Microencapsul. 1999, 16:231.
36. Choy Y.B., Cheng F., Choi H., Kim K. Macromol. Biosci. 2008, 8:758.
37. Chao P., Deshmukh M., Kutscher H.L., Gao D., Rajan S.S., Hu P., Laskin D.L., Stein S., Sinko P.J. Anticancer Drugs 2010, 21:65.
38. Dai Y., Ma P., Cheng Z., Kang X., Zhang X., Hou Z., Li C., Yang D., Zhai X., Lin J. ACS Nano 2012, 6:3327.
39. Gerweck L.E., Seetharaman K. Cancer Res. 1996, 56:1194.
40. Langman L., Burr H.S. Am. J. Obstet. Gynecol. 1949, 57:274.
41. Muvaffak A., Gurhan I., Hasirci N. J. Biomed. Mater. Res. Part B: Appl. Biomater. 2004, 71 B:295.